Incoming Lilly Australia and New Zealand General Manager Manny Simons said the results reflect an extraordinary period of progress in cardiometabolic medicines as Health Minister Mark Butler anticipates PBAC advice on reimbursing the weight-loss therapies.
Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis
December 15, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
ARCS evolves into LifeSciences Australia as part of wider strategic change
June 11, 2026 - - Latest News -
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - - Latest News -
Island secures US partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech -
Cartherics secures Japanese patent to bolster cell therapy push
June 10, 2026 - - Australian Biotech -
GSK to buy Nuvalent in a major move to acquire rights to late stage lung cancer candidates
June 10, 2026 - - Latest News -
Australian company secures US fast track for CAR-T in blood cancers
June 10, 2026 - - Latest News -
Industry campaign highlights MFN risk to US jobs and the broader economy
June 10, 2026 - - Latest News

